Adenovirus vector-mediated delivery of the CRISPR-CasRx system enables gene knockdown with suppressed collateral activity

Yuki Osakada, Sota Kidawara, Eiko Sakai, Akira Asayama, Fuminori Sakurai, Kahori Shimizu, Hiroyuki Mizuguchi · 2026

Read Adenovirus vector-mediated delivery of the CRISPR-CasRx system enables gene knockdown with suppressed collateral activity by Yuki Osakada, Sota Kidawara, Eiko Sakai, Akira Asayama, Fuminori Sakurai, Kahori Shimizu, Hiroyuki Mizuguchi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13560539.txt.

Description

The CRISPR-Cas13 system is a programmable gene knockdown tool widely used in basic and clinical research. Meanwhile, RNA-targeting by Cas13 exhibits collateral activity, i.e., cleavage of non-target RNAs, raising serious concerns. Accumulating evidence suggests the collateral activity comes from high expression levels of the Cas13 system. Therefore, controlled expression of the Cas13 system using viral vectors could solve the problem.

Catalog record

CREATORYuki Osakada, Sota Kidawara, Eiko Sakai, Akira Asayama, Fuminori Sakurai, Kahori Shimizu, Hiroyuki Mizuguchi
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE57 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13560539

Browse the full library · About the Tower of Babel